Cleared Special

CoverScan (CoverScan v1.1) (K230294) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K230294 · Perspectum · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
29d
Days
Class 2
Risk

K230294 is an FDA 510(k) clearance for the CoverScan (CoverScan v1.1). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Perspectum (Oxford, GB). The FDA issued a Cleared decision on March 3, 2023 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Low regulatory complexity profile. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Perspectum devices

Submission Details

510(k) Number K230294 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2023
Decision Date March 03, 2023
Days to Decision 29 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 107d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K230294.
InterView XP
K221984 · Mediso Medical Imaging Systems, Lttd. · Mar 2023
FlightPlan for Embolization
K223490 · GE Medical Systems SCS · Mar 2023
Syngo Carbon Space VA30A
K230561 · Siemens Healthcare GmbH · Mar 2023
Xeleris V Processing and Review System
K221680 · Ge Healthcare · Mar 2023
Advantis Platform
K222975 · Advantis Medical Imaging Single Member P.C. · Mar 2023
RealNow
K213891 · Yiwei Medical Technology Co., Ltd. · Feb 2023